Key points are not available for this paper at this time.
TANs rekrutieren Makrophagen und Treg-Zellen zu HCCs, um deren Wachstum, Fortschritt und Resistenz gegen Sorafenib zu fördern.
Zhou et al. (Sat.) untersuchten diese Frage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: